This study was designed to gain a better insight into the relationship between the serum tumor markers CEA, CYFRA 21‐1, and CA 125 and the survival outcomes of patients with stage III‐N2 NSCLC after R0 resection. Here, CEACAM5 is linked to neoplasm.